Namibia - engelsk - Namibia Medicines Regulatory Council

adcock ingram limited - amoxycillin trihydrate - capsules - each capsule contains amoxycillin trihydrate equiv. to amoxycillin 500 mg

Namibia - engelsk - Namibia Medicines Regulatory Council

rolab (pty) ltd - amoxycillin trihydrate - capsules - each capsule contains amoxycillin trihydrate equiv. to amoxycillin 250 mg.

Namibia - engelsk - Namibia Medicines Regulatory Council

sandoz (pty) limited - amoxycillin trihydrate flucloxacillin sodium monohydarate - capsules - each capsule contains amoxycillin trihydrate equiv. to amoxycillin 250 mg, flucloxacillin sodium monohydarate equiv. to flucloxa

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - potassium clavulanate; amoxicillin trihydrate -

Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - suspension - see ingredients - each 5 ml suspension contains amoxycillin trihydrate equivalent to 250 mg amoxycillin

Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

aquila healthcare (pty) ltd - suspension - see ingredients - each 5 ml suspension contains amoxycillin trihydrate equivalent to 125 mg amoxycillin

Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - capsules - see ingredients - each capsule contains amoxycillin trihydrate equivalent to amoxycillin 250,0 mg

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxycillin trihydrate; potassium clavulanate; clavulanic acid; amoxycillin -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate, quantity: 573.921 mg (equivalent: amoxicillin, qty 500 mg) - capsule, hard - excipient ingredients: croscarmellose sodium; titanium dioxide; sodium lauryl sulfate; microcrystalline cellulose; gelatin; iron oxide black; magnesium stearate; colloidal anhydrous silica; iron oxide red; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli. respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli. genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli, p. mirabilis and strep. faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate, quantity: 286.96 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: titanium dioxide; croscarmellose sodium; sodium lauryl sulfate; gelatin; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of the following infections due to susceptible strains of sensitive organisms. note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e. coli. respiratory (acute and chronic): h. influenzae; streptococcus; strep. pneumoniae; staphylococcus, non-penicillinase producing; e. coli. genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli, p. mirabilis and strep. faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.